Trial Profile
A phase II study of naloxone nasal spray for the treatment of cocaine use disorder
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Mar 2016
Price :
$35
*
At a glance
- Drugs Naloxone (Primary)
- Indications Cocaine-related disorders
- Focus Therapeutic Use
- Sponsors Opiant Pharmaceuticals
- 23 Mar 2016 New trial record
- 16 Mar 2016 According to Opiant Pharmaceuticals media release, company plans to report top-line results by 1Q17.